Loading
institutionsInstitution
Severance Hospital, Yonsei University
Severance Hospital houses Yonsei Cancer Center and Korea's first heavy-ion (carbon) therapy centre (2023).
Overview
Severance Hospital, part of Yonsei University in Seoul, houses the Yonsei Cancer Center and opened Korea's first heavy-ion carbon therapy centre in 2023; it ranks twenty-second in the Newsweek/Statista oncology list. It matters for its carbon-ion programme, for lung and gastric cancer trials, and for leadership in robotic and minimally invasive surgery, with Byoung Chul Cho, Hye Ryun Kim, Sun Young Rha, Joohyuk Sohn and Sang Joon Shin among its clinicians. OnCo links it to the MARIPOSA paper on amivantamab plus lazertinib in EGFR-mutated lung cancer and to the Korean Cancer Study Group. Whether carbon ions deliver benefits that justify the cost over protons and photons is still being worked out. Its carbon-ion and robotic surgery programmes are the reasons to read on.
Location
Seoul, KR
Type
hospital · Yonsei University
Website
Newsweek 2026 oncology rank
#22
OnCo score
#46 · 54 points (38 Newsweek + 0 NCI + 16 from 8 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Severance Hospital, including child institutions. 820 works · 10,449 citations · 73% open access · 16% clinical trials · 1% reviews.
Oncology works per year
1582022
1942023
1552024
1602025
1532026
Most works
- Byoung Chul Cho90 works
- Sun Young Rha52 works
- Chang Moo Kang51 works
- Ho Kyoung Hwang37 works
- Min Hee Hong32 works
- Sang Joon Shin31 works
- Joohyuk Sohn27 works
- Jung‐Yun Lee27 works
- Choong‐kun Lee23 works
- Si Young Song22 works
Most cited
- Carbon-ion therapy
- Robotic surgery
Byoung Chul Cho
Professor, Division of Medical Oncology; Director, Yonsei Lung Cancer Center
Lung cancerEGFR-mutant NSCLCBispecific antibodies
Co-led MARIPOSA, the trial where amivantamab plus lazertinib beat osimertinib, and a leading figure in Asian lung cancer drug development.
Hye Ryun Kim
Professor of Medical Oncology; thoracic and head-and-neck oncology
Lung cancerHead and neck cancerImmunotherapy
A Yonsei oncologist who has led checkpoint-inhibitor and combination trials in lung and head-and-neck cancer.
Joohyuk Sohn
Professor of Medical Oncology; breast cancer
Breast cancerHER2-lowAntibody-drug conjugates
Joohyuk Sohn is a Yonsei breast oncologist and investigator on the DESTINY-Breast and TROPION trials.
Sang Joon Shin
Professor of Medical Oncology; colorectal cancer and melanoma
Colorectal cancerMelanomaImmunotherapy
Sang Joon Shin is a Yonsei medical oncologist active in colorectal cancer and melanoma immunotherapy trials.
Sun Young Rha
Professor of Medical Oncology; gastric cancer
Gastric cancerImmunotherapyHER2
A gastric cancer trialist who led Korean arms of first-line immunotherapy and Claudin 18.2 studies.
Similar pages
- InstitutionQST Hospital (National Institutes for Quantum Science and Technology)
Shares Toshiba Energy Systems & Solutions, Carbon-ion synchrotrons and facilities, Carbon-ion therapy.
- InstitutionTaipei Veterans General Hospital
Shares Carbon-ion synchrotrons and facilities, Carbon-ion therapy, Gamma Knife, Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS).
- Key paperCarbon Ion Therapy: A Modern Review of an Emerging Technology
Shares Carbon-ion synchrotrons and facilities, Carbon-ion therapy.
- InstitutionSeoul National University Hospital
Shares Korean Cancer Study Group, Gamma Knife, Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS).
- InstitutionGunma University Heavy Ion Medical Center
Shares Carbon-ion synchrotrons and facilities, Carbon-ion therapy.
- InstitutionSamsung Medical Center
Shares Korean Cancer Study Group, Gamma Knife, Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS).
- TermRadiation necrosis (brain)
Shares Gamma Knife, Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS).
- CompanyHitachi (particle therapy)
Shares Carbon-ion synchrotrons and facilities, Carbon-ion therapy.